Drawing for NUTIDE

USPTO serial 79232789

NUTIDE

Reviewed by CopyMark Law Group

Reg. 5736174Status 739Registered
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
HINES, REGINA C
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with NUTIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations and substances for use in relation to the prevention, diagnosis, and treatment of cancer; pharmaceutical products for use in relation to the prevention, diagnosis, and treatment of cancer; diagnostic preparations for medical purposes for use in the field of oncology; medications for use in relation to the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations and products for the treatment of cancerACTIVE—
042Medical and scientific research in the field of cancer and oncology; science and technology services, namely, research and development of biopharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for use in clinical trials; conducting clinical trials for pharmaceutical preparations; research and development services in the fields of medicine and health; platform as a service featuring a computer software platform that enables access to technical studies and scientific and medical information; all the aforesaid services rendered in the field of oncologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 28, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 31, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 31, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jul 28, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 25, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Apr 30, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 2, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 13, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 24, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 24, 2019FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 23, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 23, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 22, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 11, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 6, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 5, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 11, 2018ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 14, 2018RFNPREFUSAL PROCESSED BY IB—
Jun 25, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 25, 2018RFRRREFUSAL PROCESSED BY MPU—
Jun 15, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 14, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2018DOCKASSIGNED TO EXAMINER—
Jun 5, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 31, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 24, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance